Becaplermin biosimilar (USV)

贝卡普勒明生物类似药 (USV)

Report date: 2025/05/06 15:48:44

Base Information

Drug NameBecaplermin biosimilar (USV)
Drug Alias NamePDGF-BBPlatelet-derived growth factor B-chain homodimer
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionPlatelet-derived growth factor receptor beta agonists
TargetsPlatelet-derived growth factor receptor beta
Therapy Area/IndicationsLower extremity diabetic neuropathic ulcers
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUSV Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUSV Pvt Ltd
Inactive CompaniesN/A
Active IndicationsLower extremity diabetic neuropathic ulcers
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A